AEST.MED.INT.HLD.SP.ADR/3 (3FMA) — Defensive Interval Ratio
AEST.MED.INT.HLD.SP.ADR/3 (3FMA) has a Defensive Interval Ratio of 5 days as of December 2025. Defensive assets of €6.40 Million (cash €-, short-term investments €-, receivables €6.40 Million) cover 5 days of daily cash needs of €1.17 Million/day. See AEST.MED.INT.HLD.SP.ADR/3 (3FMA) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
AEST.MED.INT.HLD.SP.ADR/3 Defensive Interval Ratio (2021–2025)
This chart shows how AEST.MED.INT.HLD.SP.ADR/3's Defensive Interval Ratio has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 5 days, meaning defensive assets of €6.40 Million can fund 5 days of operations without new revenue. See 3FMA equity financing ratio to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for AEST.MED.INT.HLD.SP.ADR/3 (2021–2025)
The table below presents the year-by-year Defensive Interval Ratio for AEST.MED.INT.HLD.SP.ADR/3 from 2021 to 2025, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see 3FMA market cap.
| Year | DIR (days) | Defensive Assets (EUR) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 5 days | €6.40 Million | €1.17 Million/day | €- | €- | ▼ -3 days |
| 2024 | 8 days | €8.79 Million | €1.10 Million/day | €- | €- | ▼ -1 days |
| 2023 | 9 days | €9.84 Million | €1.13 Million/day | €- | €- | ▲ +5 days |
| 2022 | 4 days | €6.19 Million | €1.49 Million/day | €- | €- | ▼ -1 days |
| 2021 | 5 days | €7.77 Million | €1.48 Million/day | €- | €- | — |